Skip to content
MS
unreviewed

alpha-Galactosidase A (GLA)

1 reactions · 1 pathways

Clinical / pharmacological. Fabry disease (X-linked)

What it does, reaction by reaction

1 reactions

Sphingolipid Degradation (Lysosomal) Lipid Metabolism · Lysosome

step 3 Irreversible/directional

Globotriaosylceramide (Gb3) -> lactosylceramide + galactose

Converts Globotriaosylceramide into Lactosylceramide Galactose

Notes

X-linked deficiency causes Fabry disease (angiokeratomas, neuropathic pain, renal failure).

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

0 entries

No regulation recorded for this enzyme in the source documents.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy.

    Søndergaard C, Nagarajah S, Shen J, Bladbjerg EM, Scholze A. · 2026-08-10

    unreviewed
  2. 2
    Vitamin K status and vascular calcification biomarkers as determinants of carotid plaque in peritoneal dialysis: a prospective study.

    Pamuk I, Cetin TE, Kindan BH, Akcay OF, Yildirim S, Sendur HN, Cerit MN, Gonen S, Akhan BM, Derici U, Guz G, … · 2026-06-22

    open access unreviewed
  3. 3
  4. 4
    Immunological fitness of echinocandin-resistant <i>Nakaseomyces glabratus</i> (former <i>Candida glabrata</i>): The impact on the management of candidemia.

    Basmaciyan L, Alvarez-Rueda N, Aldebert D, Sahnouni H, Garnaud C, Patarot D, Ducreux A, Bon F, Winckler P, Le… · 2026-05-19

    open access unreviewed
  5. 5
  6. 6
  7. 7
  8. 8
    Placental transport dysfunction in omega-3 and omega-6 fatty acid in patients with gestational diabetes mellitus.

    Long W, Guo F, Yao J, Wei Q, Yin L, Xu J, Cao X. · 2026-04-20

    open access unreviewed
  9. 9
    Development and validation of a self-management efficacy questionnaire for patients with Fabry disease in China.

    Cao ML, Zou JH, Shi MY, Sun YH, Zhao DY, Li L, Jiang HK. · 2026-04-12

    open access unreviewed
  10. 10

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.